美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

OPUS GENETICS INC

3.49

+0.11003.25%

盤後：3.48-0.0100-0.29%19:37 EST

成交量：125.92萬

成交額：434.17萬

市值：2.41億

市盈率：-1.88

高：3.57

開：3.40

低：3.33

收：3.38

52周最高：3.57

52周最低：0.6500

股本：6,896.42萬

流通股本：6,312.22萬

量比：0.69

換手率：1.99%

股息：- -

股息率：- -

每股收益(TTM):-1.8600

每股收益(LYR):-2.1535

淨資產收益率：-338.75%

總資產收益率：-60.73%

市淨率：40.34

市盈率(LYR):-1.62

資料載入中...

總覽公司新聞資訊公告

Opus Genetics, Inc.盤中異動下午盤股價大漲5.03%報3.55美元

Opus Genetics, Inc.盤中異動急速上漲5.21%

Opus Genetics, Inc.盤中異動股價大跌5.00%

Opus Genetics, Inc.盤中異動臨近收盤股價大漲5.18%

Opus Genetics獲得獨立數據監測委員會對Best病相1/2期臨牀試驗的積極建議

BUZZ--美國股票走勢-Coinbase、百思買、Abercrombie & Fitch

BUZZ--美國股票走勢-Coinbase、百思買、Abercrombie & Fitch

BUZZ-派博桑德勒給予 Opus Genetics "增持 "評級

Opus Genetics開展Opgx-Best1期1/2基因治療臨牀試驗，首位參與者已完成給藥

Opus Genetics, Inc.盤中異動早盤股價大跌5.08%報1.87美元

OPUS GENETICS INC：計劃申請FDA的新型罕見疾病證據原則（Rdep）審查流程

Opus Genetics公布OPGX-LCA5在5型Leber先天性黑矇症1/2期試驗中的積極兒科數據

Opus Genetics在關鍵性Lynx-3三期試驗中為首位患者給藥，評估0.75%酚妥拉明眼科溶液治療角膜屈光手術患者中間視覺低對比度條件下視覺障礙的療效

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/IRD/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IRD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IRD\",,,,,undefined,":{"symbol":"IRD","market":"US","secType":"STK","nameCN":"OPUS GENETICS INC","latestPrice":3.49,"timestamp":1770757200000,"preClose":3.38,"halted":0,"volume":1259235,"hourTrading":{"tag":"盘后","latestPrice":3.48,"preClose":3.49,"latestTime":"19:37 EST","volume":8044,"amount":28044.7532,"timestamp":1770770227535,"change":-0.01,"changeRate":-0.002865,"amplitude":0.005731},"delay":0,"changeRate":0.03254437869822495,"floatShares":63122173,"shares":68964208,"eps":-1.86,"marketStatus":"已收盤","change":0.11,"latestTime":"02-10 16:00:00 EST","open":3.4,"high":3.57,"low":3.33,"amount":4341675.557286,"amplitude":0.071006,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.86,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1770800400000},"marketStatusCode":5,"adr":0,"listingDate":1100235600000,"exchange":"NASDAQ","adjPreClose":3.38,"preHourTrading":{"tag":"盘前","latestPrice":3.3801,"preClose":3.38,"latestTime":"09:24 EST","volume":5351,"amount":18160.461384399998,"timestamp":1770733458967,"change":0.0001,"changeRate":0.00003,"amplitude":0.050207},"postHourTrading":{"tag":"盘后","latestPrice":3.48,"preClose":3.49,"latestTime":"19:37 EST","volume":8044,"amount":28044.7532,"timestamp":1770770227535,"change":-0.01,"changeRate":-0.002865,"amplitude":0.005731},"volumeRatio":0.685424,"impliedVol":1.6587,"impliedVolPercentile":0.8924},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IRD\",,,,,undefined,":{"symbol":"IRD","floatShares":63122173,"roa":"-60.73%","roe":"-338.75%","lyrEps":-2.153504,"volumeRatio":0.685424,"shares":68964208,"dividePrice":0,"high":3.57,"amplitude":0.071006,"preClose":3.38,"low":3.33,"week52Low":0.65,"pbRate":"40.34","psRate":"16.45","week52High":3.57,"institutionHeld":0,"latestPrice":3.49,"eps":-1.86,"divideRate":0,"volume":1259235,"delay":0,"ttmEps":-1.86,"open":3.4,"prevYearClose":2.01,"prevWeekClose":3.01,"prevMonthClose":2.31,"prevQuarterClose":2.01,"fiveDayClose":2.4,"twentyDayClose":2.05,"sixtyDayClose":1.92},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IRD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"IRD","fiscalQuarterEnding":"2025/09","expectedEps":-0.14,"name":null,"time":"盤前","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.12},{"market":"US","date":"2025-08-13","symbol":"IRD","fiscalQuarterEnding":"2025/06","expectedEps":-0.25,"name":null,"time":"盤後","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.12},{"market":"US","date":"2025-05-15","symbol":"IRD","fiscalQuarterEnding":"2025/03","expectedEps":-0.34,"name":null,"time":"盤前","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2025-03-31","symbol":"IRD","fiscalQuarterEnding":"2024/12","expectedEps":-0.34,"name":null,"time":"盤前","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"pre","actualEps":-1.27},{"market":"US","date":"2024-11-12","symbol":"IRD","fiscalQuarterEnding":"2024/09","expectedEps":-0.3,"name":null,"time":"盤前","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.29}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IRD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IRD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1818,"buy":0.8182,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8182,"analysts":11,"updateTime":1768971600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IRD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IRD","date":"2026-02-09","current":-1.876344,"percent":0,"low":-3.043594,"twenty":-2.131298,"median":-1.318782,"eighty":-1.020561,"high":-0.560128,"avg":-1.49801,"sd":0.57772,"marketCap":207582266},"quantilePoints":[{"date":"2024-10-31","current":-2.785848,"twenty":-2.857166,"median":-2.64666,"eighty":-2.37374,"marketCap":39294383},{"date":"2024-11-08","current":-2.429259,"twenty":-2.692243,"median":-2.607554,"eighty":-2.476187,"marketCap":34264702},{"date":"2024-11-15","current":-1.225421,"twenty":-2.616468,"median":-2.568551,"eighty":-2.326813,"marketCap":33321637},{"date":"2024-11-22","current":-1.142487,"twenty":-2.607554,"median":-2.49612,"eighty":-1.192247,"marketCap":31066518},{"date":"2024-11-29","current":-1.288651,"twenty":-2.607554,"median":-2.173143,"eighty":-1.193702,"marketCap":35040987},{"date":"2024-12-06","current":-1.323479,"twenty":-2.603096,"median":-1.364112,"eighty":-1.225421,"marketCap":35988040},{"date":"2024-12-13","current":-1.288651,"twenty":-2.574123,"median":-1.335088,"eighty":-1.234669,"marketCap":35040987},{"date":"2024-12-20","current":-1.14597,"twenty":-2.527405,"median":-1.303163,"eighty":-1.16559,"marketCap":31161223},{"date":"2024-12-27","current":-1.253822,"twenty":-2.505202,"median":-1.288651,"eighty":-1.163268,"marketCap":34093933},{"date":"2025-01-03","current":-1.462793,"twenty":-2.49612,"median":-1.294455,"eighty":-1.172556,"marketCap":39776255},{"date":"2025-01-10","current":-1.683372,"twenty":-2.442631,"median":-1.320577,"eighty":-1.181843,"marketCap":45774262},{"date":"2025-01-17","current":-1.346698,"twenty":-2.224366,"median":-1.346698,"eighty":-1.20274,"marketCap":36619410},{"date":"2025-01-24","current":-1.335088,"twenty":-1.87928,"median":-1.335088,"eighty":-1.207384,"marketCap":36303725},{"date":"2025-01-31","current":-1.288651,"twenty":-1.676407,"median":-1.329284,"eighty":-1.218206,"marketCap":35040987},{"date":"2025-02-07","current":-1.416355,"twenty":-1.657832,"median":-1.323479,"eighty":-1.225421,"marketCap":38513517},{"date":"2025-02-14","current":-1.335088,"twenty":-1.648544,"median":-1.323479,"eighty":-1.239294,"marketCap":36303725},{"date":"2025-02-21","current":-1.288651,"twenty":-1.616038,"median":-1.323479,"eighty":-1.250654,"marketCap":35040987},{"date":"2025-02-28","current":-1.207384,"twenty":-1.525484,"median":-1.317674,"eighty":-1.232138,"marketCap":32831195},{"date":"2025-03-07","current":-1.160946,"twenty":-1.444218,"median":-1.31187,"eighty":-1.207384,"marketCap":31568457},{"date":"2025-03-14","current":-1.07968,"twenty":-1.411711,"median":-1.30026,"eighty":-1.1772,"marketCap":29358665},{"date":"2025-03-21","current":-1.335088,"twenty":-1.404745,"median":-1.30026,"eighty":-1.16559,"marketCap":36303725},{"date":"2025-03-28","current":-1.637559,"twenty":-1.525484,"median":-1.31187,"eighty":-1.1772,"marketCap":44528506},{"date":"2025-04-04","current":-0.76585,"twenty":-1.525484,"median":-1.306065,"eighty":-1.160946,"marketCap":44060874},{"date":"2025-04-11","current":-0.564318,"twenty":-1.462793,"median":-1.288651,"eighty":-1.14388,"marketCap":32466352},{"date":"2025-04-17","current":-0.581158,"twenty":-1.453505,"median":-1.288651,"eighty":-1.129154,"marketCap":33435158},{"date":"2025-04-25","current":-0.632466,"twenty":-1.414033,"median":-1.288651,"eighty":-1.081468,"marketCap":36387058},{"date":"2025-05-02","current":-0.741567,"twenty":-1.404745,"median":-1.288651,"eighty":-1.054291,"marketCap":42663825},{"date":"2025-05-09","current":-0.787263,"twenty":-1.404745,"median":-1.277041,"eighty":-0.791089,"marketCap":45292790},{"date":"2025-05-16","current":-0.737114,"twenty":-1.402423,"median":-1.253822,"eighty":-0.755291,"marketCap":43209631},{"date":"2025-05-23","current":-0.783669,"twenty":-1.393136,"median":-1.253822,"eighty":-0.759832,"marketCap":45938661},{"date":"2025-05-30","current":-0.771642,"twenty":-1.393136,"median":-1.251182,"eighty":-0.76585,"marketCap":45233661},{"date":"2025-06-06","current":-1.017762,"twenty":-1.393136,"median":-1.225421,"eighty":-0.767335,"marketCap":59661197},{"date":"2025-06-13","current":-1.009213,"twenty":-1.381526,"median":-1.207384,"eighty":-0.771254,"marketCap":59160042},{"date":"2025-06-20","current":-0.947842,"twenty":-1.372239,"median":-1.207384,"eighty":-0.771564,"marketCap":55562472},{"date":"2025-06-27","current":-1.038117,"twenty":-1.360629,"median":-1.184165,"eighty":-0.771642,"marketCap":60854420},{"date":"2025-07-03","current":-1.017762,"twenty":-1.358307,"median":-1.160946,"eighty":-0.77653,"marketCap":59661197},{"date":"2025-07-11","current":-1.139893,"twenty":-1.351342,"median":-1.160017,"eighty":-0.782117,"marketCap":66820540},{"date":"2025-07-18","current":-1.185692,"twenty":-1.346698,"median":-1.152239,"eighty":-0.783669,"marketCap":69505294},{"date":"2025-07-25","current":-1.231492,"twenty":-1.339732,"median":-1.160017,"eighty":-0.783669,"marketCap":72190048},{"date":"2025-08-01","current":-1.129716,"twenty":-1.335088,"median":-1.160248,"eighty":-0.785825,"marketCap":66223928},{"date":"2025-08-08","current":-1.10936,"twenty":-1.335088,"median":-1.151155,"eighty":-0.789762,"marketCap":65030704},{"date":"2025-08-15","current":-1.213067,"twenty":-1.335088,"median":-1.150071,"eighty":-0.791428,"marketCap":70691504},{"date":"2025-08-22","current":-1.177087,"twenty":-1.335088,"median":-1.151155,"eighty":-0.791428,"marketCap":68594722},{"date":"2025-08-29","current":-1.287434,"twenty":-1.335088,"median":-1.160248,"eighty":-0.791428,"marketCap":75025207},{"date":"2025-09-05","current":-1.384803,"twenty":-1.335088,"median":-1.160946,"eighty":-0.797415,"marketCap":80699383},{"date":"2025-09-12","current":-1.525447,"twenty":-1.342054,"median":-1.174821,"eighty":-0.822134,"marketCap":88895414},{"date":"2025-09-19","current":-1.611997,"twenty":-1.365273,"median":-1.182227,"eighty":-0.876364,"marketCap":93939125},{"date":"2025-09-26","current":-1.860829,"twenty":-1.384803,"median":-1.184928,"eighty":-0.929339,"marketCap":108439795},{"date":"2025-10-03","current":-1.947379,"twenty":-1.400101,"median":-1.195775,"eighty":-0.939944,"marketCap":113483507},{"date":"2025-10-10","current":-2.152936,"twenty":-1.42988,"median":-1.207384,"eighty":-0.94314,"marketCap":125462322},{"date":"2025-10-17","current":-2.174573,"twenty":-1.477844,"median":-1.207384,"eighty":-0.951343,"marketCap":126723249},{"date":"2025-10-24","current":-2.163754,"twenty":-1.521119,"median":-1.217191,"eighty":-0.957164,"marketCap":126092786},{"date":"2025-10-31","current":-2.131298,"twenty":-1.627334,"median":-1.225421,"eighty":-0.958345,"marketCap":124201394},{"date":"2025-11-07","current":-2.196211,"twenty":-1.661499,"median":-1.23256,"eighty":-0.960734,"marketCap":127984177},{"date":"2025-11-14","current":-2.001473,"twenty":-1.74585,"median":-1.242213,"eighty":-0.964942,"marketCap":116635827},{"date":"2025-11-21","current":-1.951541,"twenty":-1.828372,"median":-1.253822,"eighty":-0.975077,"marketCap":133100921},{"date":"2025-11-28","current":-2.153773,"twenty":-1.878321,"median":-1.253822,"eighty":-0.98727,"marketCap":146893763},{"date":"2025-12-05","current":-2.254889,"twenty":-1.925381,"median":-1.265432,"eighty":-0.988735,"marketCap":153790183},{"date":"2025-12-12","current":-2.467233,"twenty":-1.950709,"median":-1.277041,"eighty":-0.996674,"marketCap":168272667},{"date":"2025-12-19","current":-2.002099,"twenty":-2.002099,"median":-1.288651,"eighty":-1.007767,"marketCap":136549131},{"date":"2025-12-26","current":-2.062768,"twenty":-2.022322,"median":-1.288651,"eighty":-1.0085,"marketCap":140686984},{"date":"2026-01-02","current":-2.032433,"twenty":-2.02248,"median":-1.288651,"eighty":-1.00907,"marketCap":138618058},{"date":"2026-01-09","current":-2.022322,"twenty":-2.035652,"median":-1.288651,"eighty":-1.009619,"marketCap":137928416},{"date":"2026-01-16","current":-2.103215,"twenty":-2.062768,"median":-1.30026,"eighty":-1.016154,"marketCap":143445552},{"date":"2026-01-23","current":-2.527902,"twenty":-2.079519,"median":-1.303662,"eighty":-1.017762,"marketCap":172410520},{"date":"2026-01-30","current":-2.527902,"twenty":-2.105793,"median":-1.31187,"eighty":-1.017762,"marketCap":172410520},{"date":"2026-02-06","current":-2.608795,"twenty":-2.126582,"median":-1.317674,"eighty":-1.019861,"marketCap":177927656},{"date":"2026-02-09","current":-3.043594,"twenty":-2.131298,"median":-1.318782,"eighty":-1.020561,"marketCap":207582266}],"updateTime":1770773934176},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IRD\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610672826","title":"Opus Genetics, Inc.盤中異動 下午盤股價大漲5.03%報3.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610672826","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610672826?lang=zh_tw&edition=fundamental","pubTime":"2026-02-11 04:11","pubTimestamp":1770754308,"startTime":"0","endTime":"0","summary":"北京时间2026年02月11日04时11分，Opus Genetics, Inc.股票出现异动，股价大幅拉升5.03%。Opus Genetics, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。Opus Genetics, Inc.公司简介：Opus Genetics Inc是一家临床阶段的眼科生物制药公司，开发治疗遗传性视网膜疾病患者的疗法，以及治疗其他视网膜和屈光性疾病患者的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211041148a494ca59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211041148a494ca59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCA","BK4139","IRD","BK4007"],"gpt_icon":0},{"id":"2609231598","title":"Opus Genetics, Inc.盤中異動 急速上漲5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609231598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609231598?lang=zh_tw&edition=fundamental","pubTime":"2026-02-06 00:28","pubTimestamp":1770308922,"startTime":"0","endTime":"0","summary":"北京时间2026年02月06日00时28分，Opus Genetics, Inc.股票出现异动，股价快速拉升5.21%。Opus Genetics, Inc.股票所在的生物技术行业中，整体跌幅为0.71%。Opus Genetics, Inc.公司简介：Opus Genetics Inc是一家临床阶段的眼科生物制药公司，开发治疗遗传性视网膜疾病患者的疗法，以及治疗其他视网膜和屈光性疾病患者的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020600284297a512a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020600284297a512a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LCA","BK4139","IRD"],"gpt_icon":0},{"id":"2609305774","title":"Opus Genetics, Inc.盤中異動 股價大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609305774","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609305774?lang=zh_tw&edition=fundamental","pubTime":"2026-02-04 23:55","pubTimestamp":1770220528,"startTime":"0","endTime":"0","summary":"北京时间2026年02月04日23时55分，Opus Genetics, Inc.股票出现异动，股价急速下挫5.00%。Opus Genetics, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。Opus Genetics, Inc.公司简介：Opus Genetics Inc是一家临床阶段的眼科生物制药公司，开发治疗遗传性视网膜疾病患者的疗法，以及治疗其他视网膜和屈光性疾病患者的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204235529953fd83a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204235529953fd83a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCA","BK4139","BK4007","IRD"],"gpt_icon":0},{"id":"2603633716","title":"Opus Genetics, Inc.盤中異動 臨近收盤股價大漲5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603633716","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603633716?lang=zh_tw&edition=fundamental","pubTime":"2026-01-13 04:31","pubTimestamp":1768249879,"startTime":"0","endTime":"0","summary":"北京时间2026年01月13日04时31分，Opus Genetics, Inc.股票出现波动，股价快速上涨5.18%。Opus Genetics, Inc.股票所在的生物技术行业中，整体跌幅为1.21%。Opus Genetics, Inc.公司简介：Opus Genetics Inc是一家临床阶段的眼科生物制药公司，开发治疗遗传性视网膜疾病患者的疗法，以及治疗其他视网膜和屈光性疾病患者的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113043119953c7534&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113043119953c7534&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IRD","LCA","BK4007"],"gpt_icon":0},{"id":"1119412428","title":"Opus Genetics獲得獨立數據監測委員會對Best病相1/2期臨牀試驗的積極建議","url":"https://stock-news.laohu8.com/highlight/detail?id=1119412428","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119412428?lang=zh_tw&edition=fundamental","pubTime":"2025-12-09 20:06","pubTimestamp":1765282015,"startTime":"0","endTime":"0","summary":"Opus Genetics获得独立数据监测委员会对Best病相1/2期临床试验的积极建议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRD","BK4139","BK4007"],"gpt_icon":0},{"id":"2586507479","title":"BUZZ--美國股票走勢-Coinbase、百思買、Abercrombie & Fitch","url":"https://stock-news.laohu8.com/highlight/detail?id=2586507479","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586507479?lang=zh_tw&edition=fundamental","pubTime":"2025-11-25 22:16","pubTimestamp":1764080173,"startTime":"0","endTime":"0","summary":"nL6N3X10P9 ** Zeta Global Holdings Corp ZETA.N：BUZZ - 在上调季度和年度预测后上涨   nL4N3X10Q2 ** Vistra Corp VST.N：BUZZ--KeyBanc给予Vistra \"增持 \"评级。nL6N3X10S3 ** PTC Therapeutics PTCT.O：BUZZ - 该公司将加入标准普尔小型股指数，有望再创新高   nL6N3X10RH ** Firefly Aerospace Inc FLY.O：BUZZ - 因推迟上市，摩根大通下调Firefly Aerospace的PT值   nL6N3X10SL ** Lixte Biotechnology Holdings Inc LIXT.O：BUZZ - 收购英国公司，进军质子治疗癌症领域，股价上涨   nL4N3X10WN ** Keysight Technologies Inc KEYS.N：BUZZ - 因乐观的第一季度预测而跳涨；券商上调了预测价值   nL4N3X10TP (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nL4T3X10Z1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATAT","LU1301847155.USD","LU0689472784.USD","BBY","ESPR","FLY","LU0943347566.SGD","TITN","LU0531971595.HKD","LU2491049909.HKD","ANF","COIN","AU","IRD","ADI","LU0994945656.USD","KEYS","FIBK","ABCB","FLNC","APD","ALBmain","LU0496367417.USD","ZETA","DD","LIXT","LU2237443978.SGD","SYM","HBBD.SI","UPWK","IE00BFMHRM44.USD","CDE","EXOD","ZM","PTCT","LU0708995401.HKD","LU2360107325.USD","89988","HL","VST","SPOT","BK1610"],"gpt_icon":1},{"id":"2586479501","title":"BUZZ--美國股票走勢-Coinbase、百思買、Abercrombie & Fitch","url":"https://stock-news.laohu8.com/highlight/detail?id=2586479501","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586479501?lang=zh_tw&edition=fundamental","pubTime":"2025-11-25 22:16","pubTimestamp":1764080173,"startTime":"0","endTime":"0","summary":"nL6N3X10P9 ** Zeta Global Holdings Corp ZETA.N：BUZZ - 在上调季度和年度预测后上涨   nL4N3X10Q2 ** Vistra Corp VST.N：BUZZ--KeyBanc给予Vistra \"增持 \"评级。nL6N3X10S3 ** PTC Therapeutics PTCT.O：BUZZ - 该公司将加入标准普尔小型股指数，有望再创新高   nL6N3X10RH ** Firefly Aerospace Inc FLY.O：BUZZ - 因推迟上市，摩根大通下调Firefly Aerospace的PT值   nL6N3X10SL ** Lixte Biotechnology Holdings Inc LIXT.O：BUZZ - 收购英国公司，进军质子治疗癌症领域，股价上涨   nL4N3X10WN ** Keysight Technologies Inc KEYS.N：BUZZ - 因乐观的第一季度预测而跳涨；券商上调了预测价值   nL4N3X10TP (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nL4S3X10Z1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FLNC","LU0348783662.USD","LU1003077747.HKD","SG9999015945.SGD","ATAT","SYM","ADI","TITN","LU0543330483.HKD","COIN","UPWK","ZETA","ANF","BBY","LU0128525929.USD","89988","EXOD","LU0289960550.SGD","CDE","DD","IE00B543WZ88.USD","LU1211504680.USD","VST","KEYS","IRD","ESPR","BK4101","HL","ZM","FIBK","HBBD.SI","LU0700851271.USD","ABCB","PTCT","AU","LU0070302665.USD","SG9999001093.SGD","ALBmain","LIXT","SPOT","FLY","APD"],"gpt_icon":1},{"id":"2586420356","title":"BUZZ-派博桑德勒給予 Opus Genetics \"增持 \"評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2586420356","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586420356?lang=zh_tw&edition=fundamental","pubTime":"2025-11-25 20:03","pubTimestamp":1764072216,"startTime":"0","endTime":"0","summary":"BUZZ-派博桑德勒给予 Opus Genetics \"增持 \"评级11月25日 - ** Piper Sandler启动了对Opus Genetics IRD.O的覆盖，给予 \"增持 \"评级；将目标价定为7美元，与该股上次收盘价相比有约250%的上涨空间** 处于临床阶段的生物制药公司股价盘前上涨 4.5% 至 2.09 美元 ** IRD的主导项目OPGx-LCA5在一种超罕见眼病(LCA5的早期临床数据强劲，券商因此看好IRD。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nL4S3X10QZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRD","BK4007","BK4139"],"gpt_icon":0},{"id":"1159635757","title":"Opus Genetics開展Opgx-Best1期1/2基因治療臨牀試驗，首位參與者已完成給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=1159635757","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159635757?lang=zh_tw&edition=fundamental","pubTime":"2025-11-13 20:01","pubTimestamp":1763035272,"startTime":"0","endTime":"0","summary":"Opus Genetics开展Opgx-Best1期1/2基因治疗临床试验，首位参与者已完成给药","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","IRD"],"gpt_icon":0},{"id":"2582341941","title":"Opus Genetics, Inc.盤中異動 早盤股價大跌5.08%報1.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582341941","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582341941?lang=zh_tw&edition=fundamental","pubTime":"2025-11-11 23:33","pubTimestamp":1762875222,"startTime":"0","endTime":"0","summary":"北京时间2025年11月11日23时33分，Opus Genetics, Inc.股票出现异动，股价急速下挫5.08%。Opus Genetics, Inc.股票所在的生物技术行业中，整体涨幅为0.62%。Opus Genetics, Inc.公司简介：Opus Genetics Inc是一家临床阶段的眼科生物制药公司，开发治疗遗传性视网膜疾病患者的疗法，以及治疗其他视网膜和屈光性疾病患者的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111233342a6f254df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111233342a6f254df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCA","IRD","BK4139","BK4007"],"gpt_icon":0},{"id":"1182430757","title":"OPUS GENETICS INC：計劃申請FDA的新型罕見疾病證據原則（Rdep）審查流程","url":"https://stock-news.laohu8.com/highlight/detail?id=1182430757","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182430757?lang=zh_tw&edition=fundamental","pubTime":"2025-11-06 20:12","pubTimestamp":1762431137,"startTime":"0","endTime":"0","summary":"OPUS GENETICS INC：计划申请FDA的新型罕见疾病证据原则（Rdep）审查流程","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IRD","BK4139"],"gpt_icon":0},{"id":"1153491222","title":"Opus Genetics公布OPGX-LCA5在5型Leber先天性黑矇症1/2期試驗中的積極兒科數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1153491222","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153491222?lang=zh_tw&edition=fundamental","pubTime":"2025-09-30 19:04","pubTimestamp":1759230270,"startTime":"0","endTime":"0","summary":"Opus Genetics公布了其OPGX-LCA5药物在治疗5型Leber先天性黑矇症（LCA5）的1/2期临床试验中获得的积极儿科患者数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRD","BK4139","BK4007"],"gpt_icon":0},{"id":"1194408460","title":"Opus Genetics在關鍵性Lynx-3三期試驗中為首位患者給藥，評估0.75%酚妥拉明眼科溶液治療角膜屈光手術患者中間視覺低對比度條件下視覺障礙的療效","url":"https://stock-news.laohu8.com/highlight/detail?id=1194408460","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194408460?lang=zh_tw&edition=fundamental","pubTime":"2025-09-04 20:05","pubTimestamp":1756987523,"startTime":"0","endTime":"0","summary":"Opus Genetics公司宣布，在其关键性Lynx-3三期临床试验中成功为第一位患者给药。该试验旨在评估0.75%酚妥拉明眼科溶液在治疗角膜屈光手术患者中间视觉、低对比度条件下视觉障碍方面的有效性和安全性。\n这项重要的三期临床试验标志着该公司在眼科治疗领域取得的重要进展，为那些在中间光照和低对比度环境下出现视觉困扰的角膜屈光手术患者提供了新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRD","BK4007","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":13,"code":"91000000","status":"200"}]}}